References
- ACOG. 2013. Hypertension in pregnancy. Report of the american college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 122(5):1122.
- al Embarazo A, Ma S, JC B, Cadavid A, Cadavid A. 2007. A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant. 22(5):1477–1490. doi:https://doi.org/10.1093/ndt/gfl804.
- Alonso G, Gallibert E, Lafont C, Guillon G. 2008. Intrahypothalamic angiogenesis induced by osmotic stimuli correlates with local hypoxia: a potential role of confined vasoconstriction induced by dendritic secretion of vasopressin. Endocrinology. 149(9):4279–4288. doi:https://doi.org/10.1210/en.2008-0387.
- Anastasio P, Cirillo M, Spitali L, Frangiosa A, Pollastro RM, De Santo NG. 2001. Level of hydration and renal function in healthy humans. Kidney Int. 60(2):748–756. doi:https://doi.org/10.1046/j.1523-1755.2001.060002748.x.
- Baijnath S, Murugesan S, Mackraj I, Gathiram P, Moodley J. 2017. The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia. Mol Cell Biochem. 427(1–2):59–67. doi:https://doi.org/10.1007/s11010-016-2897-5.
- Baijnath S, Soobryan N, Mackraj I, Gathiram P, Moodley J. 2014. The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 182:71–75. doi:https://doi.org/10.1016/j.ejogrb.2014.08.021.
- Bankir L, Bardoux P, Ahloulay M. 2001. Vasopressin and diabetes mellitus. Nephron. 87(1):8–18. doi:https://doi.org/10.1159/000045879.
- Bankir L, Bichet D, Morgenthaler N. 2017. Vasopressin: physiology, assessment and osmosensation. J Intern Med. 282(4):284–297. doi:https://doi.org/10.1111/joim.12645.
- Barton JR, Sibai BM. 2004. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 31(4):807–833. doi:https://doi.org/10.1016/j.clp.2004.06.008.
- Bolignano D, Zoccali C. 2010. Vasopressin beyond water: implications for renal diseases. Curr Opin Nephrol Hypertens. 19(5):499–504. doi:https://doi.org/10.1097/MNH.0b013e32833d35cf.
- Barrett KE, Barman S, Boitano S, Brooks H. 2010. Pulmonary Function, Ch-35. Ganong’s review of medical physiology, 23rd Edition. 23rd ed. New Delhi: Tata McGraw Hill. p. 587-638.
- Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. 2018. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 72(1):24–43. doi:https://doi.org/10.1161/HYPERTENSIONAHA.117.10803.
- Buchwalter A, Van Dort C, Schultz S, Smith R, Le I, Abbott J, Oosterhouse E, Johnson A, Hansen-Smith F, Burnatowska-Hledin M. 2008. Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype. Microvasc Res. 75(2):155–168. doi:https://doi.org/10.1016/j.mvr.2007.08.004.
- Burton G, Sebire N, Myatt L, Tannetta D, Wang Y-L, Sadovsky Y, Staff A, Redman C. 2014. Optimising sample collection for placental research. Placenta. 35(1):9–22. doi:https://doi.org/10.1016/j.placenta.2013.11.005.
- Carakostas MC, Power RJ, Banerjee AK. 1990. Serum 5’Nucleotidase activity in rats: a method for automated analysis and criteria for interpretation. Vet Clin Pathol. 19(4):109–113. doi:https://doi.org/10.1111/j.1939-165X.1990.tb00555.x.
- Chen A, Lee K, D’Agati VD, Wei C, Fu J, Guan T-J, He JC, Schlondorff D, Agudo J. 2018. Bowman’s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J Clin Invest. 128(8):3413–3424. doi:https://doi.org/10.1172/JCI97879.
- Cheng M-H, Wang P-H. 2009. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Rev Mol Diagn. 9(1):37–49. doi:https://doi.org/10.1586/14737159.9.1.37.
- Cortés-Vásquez J, Noreña I, Mockus I. 2018. Hypertriglyceridemia and adverse outcomes during pregnancy. Revista de la Facultad de Medicina. 66(2):247–253. doi:https://doi.org/10.15446/revfacmed.v66n2.60791.
- Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA, Graham CH. 2014. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 211(1):165–179. doi:https://doi.org/10.1084/jem.20130295.
- Crews JK, Herrington JN, Granger JP, Khalil RA. 2000. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 35(1):367–372. doi:https://doi.org/10.1161/01.HYP.35.1.367.
- D’Souza Z, McAdoo SP, Smith J, Pusey CD, Cook HT, Behmoaras J, Aitman TJ. 2013. Experimental crescentic glomerulonephritis: a new bicongenic rat model. Dis Model Mech. 6(6):1477–1486.
- Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. 2016. Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Medical Archives. 70(1):44. doi:https://doi.org/10.5455/medarh.2016.70.44-47.
- Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN. 2002. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension. 39(2):337–342. doi:https://doi.org/10.1161/hy02t2.102904.
- Dixon TF, Purdom M. 1954. Serum 5-nucleotidase. J Clin Pathol. 7(4):341–343. doi:https://doi.org/10.1136/jcp.7.4.341.
- Dobsa L, Edozien KC. 2013. Copeptin and its potential role in diagnosis and prognosis of various diseases. Biochemia Medica. 23(2):172–190. doi:https://doi.org/10.11613/BM.2013.021.
- Eaton M, Davies AH, Devine J, Zhao X, Simmons DG, Maríusdóttir E, Natale DR, Matyas JR, Bering EA, Workentine ML. 2020. Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction. PLoS One. 15(1):e0226735. doi:https://doi.org/10.1371/journal.pone.0226735.
- El Khouly NI, Sanad ZF, Saleh SA, Shabana AA, Elhalaby AF, Badr EE. 2016. Value of first-trimester serum lipid profile in early prediction of preeclampsia and its severity: a prospective cohort study. Hypertens Pregnancy. 35(1):73–81. doi:https://doi.org/10.3109/10641955.2015.1115060.
- Elenkov IJ, Chrousos GP. 2006. Stress System – organization, Physiology and Immunoregulation. Neuroimmunomodulation. 13(5–6):257–267. doi:https://doi.org/10.1159/000104853.
- Emamian M, Hasanian SM, Tayefi M, Bijari M, Movahedian Far F, Shafiee M, Avan A, Heidari‐Bakavoli A, Moohebati M, Ebrahimi M. 2017. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 31(6):e22124. doi:https://doi.org/10.1002/jcla.22124.
- Ferrazzani S, Luciano R, Garofalo S, D’Andrea V, De Carolis S, De Carolis MP, Paolucci V, Romagnoli C, Caruso A. 2011. Neonatal outcome in hypertensive disorders of pregnancy. Early Hum Dev. 87(6):445–449. doi:https://doi.org/10.1016/j.earlhumdev.2011.03.005.
- Fischer AH, Jacobson KA, Rose J, Zeller R. 2008. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008(6):4986. doi:https://doi.org/10.1101/pdb.prot4986.
- Furukawa S, Hayashi S, Usuda K, Abe M, Hagio S, Ogawa I. 2011. Toxicological pathology in the rat placenta. J Toxicol Pathol. 24(2):95–111. doi:https://doi.org/10.1293/tox.24.95.
- Gilbert JS, Nijland MJ, Knoblich P. 2008. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Expert Rev Cardiovasc Ther. 6(10):1367–1377. doi:https://doi.org/10.1586/14779072.6.10.1367.
- Gillis EE, Mooney JN, Garrett MR, Granger JP, Sasser JM. 2016. Sildenafil treatment ameliorates the maternal syndrome of preeclampsia and rescues fetal growth in the dahl salt–sensitive rat. Hypertension. 67(3):647–653. doi:https://doi.org/10.1161/HYPERTENSIONAHA.115.06071.
- Gohil J, Patel P, Gupta P. 2011. Estimation of lipid profile in subjects of preeclampsia. The Journal of Obstetrics and Gynecology of India. 61(4):399. doi:https://doi.org/10.1007/s13224-011-0057-0.
- Goldsmith SR. 2005. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am J Cardiol. 95(9):14–23. doi:https://doi.org/10.1016/j.amjcard.2005.03.004.
- Goldsmith SR, Gheorghiade M. 2005. Vasopressin antagonism in heart failure. J Am Coll Cardiol. 46(10):1785–1791. doi:https://doi.org/10.1016/j.jacc.2005.02.095.
- Govender L, Mackraj I, Gathiram P, Moodley J. 2012. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women : early- versus late-onset pre-eclampsia. Cardiovasc J Afr. 23(3):153. doi:https://doi.org/10.5830/CVJA-2012-003.
- Govender N, Ramdin S, Reddy R, Naicker T. 2021. Transforming growth factor-beta and liver injury in an arginine vasopressin-induced pregnant rat model. Clin Exp Reprod Med. 48(2):124. doi:https://doi.org/10.5653/cerm.2020.04035.
- Guelinckx I, Vecchio M, Perrier ET, Lemetais G. 2016. Fluid intake and vasopressin: connecting the dots. Ann Nutr Metab. 68(Suppl. 2):6–11. doi:https://doi.org/10.1159/000446198.
- Guida JP, Parpinelli MA, Surita FG, Costa ML. 2018. The impact of proteinuria on maternal and perinatal outcomes among women with pre-eclampsia. International Journal of Gynecology & Obstetrics. 143(1):101–107. doi:https://doi.org/10.1002/ijgo.12487.
- Gupta A, Bhandari N, Kharb S, Chauhan M. 2019. Lactate dehydrogenase levels in preeclampsia and its correlation with maternal and perinatal outcome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 8(4):1506.
- Gutierrez C, Blanchard DG. 2004. Diastolic heart failure: the challenges of diagnosis and treatment. Am Fam Physician. 69(11):2609–2616.
- Haddad B, Kayem G, Deis S, Sibai BM. 2007. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol. 196(3):237. e231-237. e235. https://doi.org/10.1016/j.ajog.2006.10.905.
- Hems DA, Whitton PD, Ma GY. 1975. Metabolic actions of vasopressin, glucagon and adrenalin in the intact rat. Biochimica Et Biophysica Acta (Bba)-general Subjects. 411(1):155–164. doi:https://doi.org/10.1016/0304-4165(75)90294-9.
- Hershkovitz R, Ohel I, Sheizaf B, Nathan I, Erez O, Sheiner E, Pinku A, Mazor M. 2005. Erythropoietin concentration among patients with and without preeclampsia. Arch Gynecol Obstet. 273(3):140–143. doi:https://doi.org/10.1007/s00404-005-0013-2.
- Hiroyama M, Aoyagi T, Fujiwara Y, Birumachi J, Shigematsu Y, Kiwaki K, Tasaki R, Endo F, Tanoue A. 2007. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Molecular Endocrinology. 21(1):247–258. doi:https://doi.org/10.1210/me.2006-0069.
- Hu D, Cross JC. 2009. Development and function of trophoblast giant cells in the rodent placenta. Int J Dev Biol. 54(2–3):341–354. doi:https://doi.org/10.1387/ijdb.082768dh.
- Huang S-HS, Sharma AP, Yasin A, Lindsay RM, Clark WF, Filler G. 2011. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clinical Journal of the American Society of Nephrology. 6(2):274–280. doi:https://doi.org/10.2215/CJN.02760310.
- Huang X, Jain A, Baumann M, Körner M, Surbek D, Bütikofer P, Albrecht C. 2013. Increased placental phospholipid levels in pre-eclamptic pregnancies. Int J Mol Sci. 14(2):3487–3499. doi:https://doi.org/10.3390/ijms14023487.
- Indumati V, Kodliwadmath M, Sheela M. 2011. The role of serum electrolytes in pregnancy induced hypertension. Journal of Clinical and Diagnostic Research. 5(1):66–69.
- Jablonskis LT, Howe PR. 1993. Vasopressin compensates for acute loss of sympathetic pressor tone in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 20(5):380–383. doi:https://doi.org/10.1111/j.1440-1681.1993.tb01711.x.
- Jeyabalan A. 2013. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 71(suppl_1):S18–S25. doi:https://doi.org/10.1111/nure.12055.
- Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA. 2003. Expression of podocyte-associated molecules in acquired human kidney diseases. Journal of the American Society of Nephrology. 14(8):2063–2071. doi:https://doi.org/10.1097/01.ASN.0000078803.53165.C9.
- Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. 2012. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 92(4):1813–1864. doi:https://doi.org/10.1152/965physrev.00035.2011.
- Lee CR, Watkins ML, Patterson JH, Gattis W, O’Connor CM, Gheorghiade M, Adams JKF. 2003. Vasopressin: a new target for the treatment of heart failure. Am Heart J. 146(1):9–18. doi:https://doi.org/10.1016/S0002-8703(02)94708-3.
- Li G, Ma L, Lin L, Wang Y-l YH, Yang H. 2018. The intervention effect of aspirin on a lipopolysaccharide-induced preeclampsia-like mouse model by inhibiting the nuclear factor-κB pathway†. Biol Reprod. 99(2):422–432. doi:https://doi.org/10.1093/biolre/ioy025.
- Li J, LaMarca B, Reckelhoff JF. 2012. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. American Journal of Physiology-Heart and Circulatory Physiology. 303(1):H1–H8. doi:https://doi.org/10.1152/ajpheart.00117.2012.
- Lima VJD, Andrade CRD, Ruschi GE, Sass N. 2011. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Medical Journal. 129(2):73–76. doi:https://doi.org/10.1590/S1516-31802011000200004.
- Lorell BH, Carabello BA. 2000. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 102(4):470–479. doi:https://doi.org/10.1161/01.CIR.102.4.470.
- Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A. 2005. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. Journal of Biological Chemistry. 280(51):41928–41939. doi:https://doi.org/10.1074/jbc.M508718200.
- Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. 2014. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension. 64(1):36–44. doi:https://doi.org/10.1161/HYPERTENSIONAHA.113.02766.
- Makuyana D, Mahomed K, Shukusho F, Majoko F. 2002. Liver and kidney function tests in normal and pre-eclamptic gestation: a comparison with non-gestational reference values. Central African Journal of Medicine. 48(5/6):55–59.
- Manjareeka M, Nanda S. 2013. Elevated levels of serum uric acid, creatinine or urea in preeclamptic women. International Journal of Medical Science and Public Health. 2(1):43–47. doi:https://doi.org/10.5455/ijmsph.2013.2.43-47.
- Marshall SA, Hannan NJ, Jelinic M, Nguyen TPH, Girling JE, Parry LJ. 2018. Animal models of preeclampsia: translational failings and why. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 314(4):R499–R508. doi:https://doi.org/10.1152/ajpregu.00355.2017.
- Mayer B, Nemeth K, Krepuska M, Myneni VD, Maric D, Tisdale JF, Hsieh MM, Uchida N, Lee HJ, Nemeth MJ, et al. 2017. Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemia. Sci Transl Med. 9(418):eaao1632. doi:https://doi.org/10.1126/scitranslmed.aao1632
- Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111(5):649–658. doi:https://doi.org/10.1172/JCI17189
- Mayret-Mesquiti M, Pérez-Méndez O, Rodríguez ME, Fortoul TI, Gorocica P, Bernal-Alcántara D, Montaño LF, Alvarado-Vasquez N. 2007. Hypertriglyceridemia is linked to reduced nitric oxide synthesis in women with hypertensive disorders of pregnancy. Hypertens Pregnancy. 26(4):423–431. doi:https://doi.org/10.1080/10641950701521569.
- Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, Majurec I, Brncic-Fischer A, Sobocan N, Hrstic I, Stimac T, Stimac D, Milic S. 2018. Liver disease during pregnancy: a challenging clinical issue. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 24:4080–4090. doi:https://doi.org/10.12659/MSM.907723.
- Motta C, Grosso C, Zanuzzi C, Molinero D, Picco N, Bellingeri R, Alustiza F, Barbeito C, Vivas A, Romanini MC. 2015. Effect of Sildenafil on Pre-eclampsia-like mouse model induced by L-name. Reproduction in Domestic Animals. 50(4):611–616. doi:https://doi.org/10.1111/rda.12536.
- Müller-Deile J, Schiffer M. 2011. Renal involvement in preeclampsia: similarities to VEGF ablation therapy. J Pregnancy. vol 2011.
- Niromanesh S, Shirazi M, Dastgerdy E, Sharbaf F, Shirazi M, Khazaeipour Z. 2012. Association of hypertriglyceridaemia with pre-eclampsia, preterm birth, gestational diabetes and uterine artery pulsatility index. Natl Med J India. 25(5):265–267.
- Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. 2000. Preeclampsia and fetal growth. Obstet Gynecol. 96(6):950–955.
- Özkara A, Kaya AE, Başbuğ A, Ökten SB, Doğan O, Çağlar M, Kumru S. 2018. Proteinuria in preeclampsia: is it important? Ginekol Pol. 89(5):256–261. doi:https://doi.org/10.5603/GP.a2018.0044.
- Patil S, Jyothi A, Babu A, Goud G. 2016. A study on Liver function tests and Renal function tests in Preeclampsia. International Journal of Biomedical Research. 10:713–717.
- Qian Q. 2018. Salt, water and nephron: mechanisms of action and link to hypertension and chronic kidney disease. Nephrology. 23:44–49. doi:https://doi.org/10.1111/nep.13465.
- Qublan H, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I, Khreisat B, Nussair B, Amarin Z. 2005. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia. Medical Science Monitor. 11(8):CR393–CR397.
- Rasmussen S, Irgens LM. 2003. Fetal growth and body proportion in preeclampsia. Obstet Gynecol. 101(3):575–583.
- Russell JA, Walley KR. 2010. Vasopressin and its immune effects in septic shock. J Innate Immun. 2(5):446–460. doi:https://doi.org/10.1159/000318531.
- Saha T, Halder M, Das A, Das SK. 2013. Role of nitric oxide, angiogenic growth factors and biochemical analysis in preeclampsia. Indian J Biochem Biophys. 50(5):462–466.
- Sandgren JA, Deng G, Linggonegoro DW, Scroggins SM, Perschbacher KJ, Nair AR, Nishimura TE, Zhang SY, Agbor LN, Wu J. 2018. Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight. 3(19):19. doi:https://doi.org/10.1172/jci.insight.99403.
- Sandgren JA, Scroggins SM, Santillan DA, Devor EJ, Gibson-Corley KN, Pierce GL, Sigmund CD, Santillan MK, Grobe JL. 2015. Vasopressin: the missing link for preeclampsia? Am J Physiol Regul Integr Comp Physiol. 309(9):R1062–1064. doi:https://doi.org/10.1152/ajpregu.00073.2015.
- Santillan MK, Santillan DA, Scroggins SM, Min JY, Sandgren JA, Pearson NA, Leslie KK, Hunter SK, Zamba GK, Gibson-Corley KN. 2014. Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension. 64(4):852–859. doi:https://doi.org/10.1161/HYPERTENSIONAHA.114.03848.
- Siddiqui IA, Jaleel A, Al Kadri HM, Al Saeed W, Tamimi W. 2011. Iron status parameters in preeclamptic women. Arch Gynecol Obstet. 284(3):587–591. doi:https://doi.org/10.1007/s00404-010-1728-2.
- Soares MJ, Chakraborty D, Kubota K, Renaud SJ, Rumi MK. 2014. Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy. Int J Dev Biol. 58(2–3–4):247. doi:https://doi.org/10.1387/ijdb.140083ms.
- Sones JL, Davisson RL. 2016. Preeclampsia, of mice and women. Physiol Genomics. 48(8):565–572. doi:https://doi.org/10.1152/physiolgenomics.00125.2015.
- Song J, Martin DS. 2006. Rho kinase contributes to androgen amplification of renal vasoconstrictor responses in the spontaneously hypertensive rat. J Cardiovasc Pharmacol. 48(3):103–109. doi:https://doi.org/10.1097/01.fjc.0000245403.45406.d8.
- Spradley FT, Tan AY, Joo WS, Daniels G, Kussie P, Karumanchi SA, Granger JP. 2016. Placental growth factor administration abolishes placental ischemia-induced hypertension. Hypertension. 67(4):740–747. doi:https://doi.org/10.1161/HYPERTENSIONAHA.115.06783.
- Tanacan A, Fadiloglu E, Beksac MS. 2019. The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes. Hypertens Pregnancy. 38(2):111–118. doi:https://doi.org/10.1080/10641955.2019.1590718.
- Taveau C, Chollet C, Bichet DG, Velho G, Guillon G, Corbani M, Roussel R, Bankir L, Melander O, Bouby N. 2016. Acute and chronic hyperglycemic effects of vasopressin in normal rats involvement of V1A receptors. American Journal of Physiology-Endocrinology and Metabolism. 312(3):E127–E135. doi:https://doi.org/10.1152/ajpendo.00269.2016.
- Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. 2012. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab. 97(11):3917–3925. doi:https://doi.org/10.1210/jc.2012-1295.
- Weiner E, Schreiber L, Grinstein E, Feldstein O, Rymer-Haskel N, Bar J, Kovo M. 2016. The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome. Placenta. 47:99–104. doi:https://doi.org/10.1016/j.placenta.2016.09.012.
- White IPF, Wantania JJ, Mewengkang ME. 2019. Differences in serum lipid profile value in pregnancy and postpartum on severe preeclampsia. Indonesian Journal of Obstetrics and Gynecology. 7(1):15–20.
- Yeung EH, Liu A, Mills JL, Zhang C, Männistö T, Lu Z, Tsai MY, Mendola P. 2014. Increased levels of copeptin before clinical diagnosis of preeclampsia. Hypertension. 64(6):1362–1367. doi:https://doi.org/10.1161/HYPERTENSIONAHA.114.03762.
- Zhang C, Zhu Y, Shen Y, Zuo C. 2018. Aspirin ameliorates preeclampsia induced by a peroxisome proliferator-activated receptor antagonist. Reproductive Sciences. 25(12):1655–1662. doi:https://doi.org/10.1177/1933719118756746.
- Zhu M, Ren Z, Possomato-Vieira JS, Khalil RA. 2016. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 311(3):R505–R521. doi:https://doi.org/10.1152/ajpregu.00137.2016.
- Zulfikaroglu E, Islimye M, Tonguc EA, Payasli A, Isman F, Var T, Danisman N. 2011. Circulating levels of copeptin, a novel biomarker in pre-eclampsia. Journal of Obstetrics and Gynaecology Research. 37(9):1198–1202. doi:https://doi.org/10.1111/j.1447-0756.2010.01498.x.